Slimy business--the biotechnology of biofilms.
Schachter
Beth
B
bschachter@nasw.org
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001424:Bacterial Infections / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D001672:Biocompatible Materials / Q000009:adverse effects*; D018441:Biofilms / Q000187:drug effects* / Q000254:growth & development*; D001709:Biotechnology / Q000191:economics / Q000379:methods / Q000639:trends; D004352:Drug Resistance, Microbial / Q000502:physiology; D004866:Equipment Contamination; D004864:Equipment and Supplies / Q000009:adverse effects; D015964:Gene Expression Regulation, Bacterial / Q000502:physiology; D006801:Humans; D016459:Prosthesis-Related Infections / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D013499:Surface Properties; D014481:United States
D000900:Anti-Bacterial Agents; D001672:Biocompatible Materials